Benitec Biopharma and Medistem Technologies Successfully Combined in...
SYDNEY, AUSTRALIA and SAN DIEGO, CA -- -- 02/06/12 -- Benitec Biopharma and Medistem announced today the successful treatment of rheumatoid arthritis in preclinical models using Benitec Biopharma's patented gene silencing technology applied to stem cell-derived immune system cells called dendritic cells.
Join the discussion below, or Read more at Sys-Con Media.
#1 Feb 14, 2012
It is a very innovative idea to combine stem cells with siRNA or in benitec's case shRNA
Add your comments below
|More Than 300 Operators Now Using PeerApp Ultra... (Mar '13)||Mar '13||Tony||1|
|Infortrend's Flagship ZFS-Based Nas Offers 8 GB... (Dec '12)||Dec '12||Ernest Berkoh||1|
|Chick-Fil-A'd: Bully Fired After Video Goes Viral (Aug '12)||Aug '12||TheBlackSheep||1|
|Abitibi Royalties Inc./Malartic CHL Joint Ventu... (Feb '12)||Feb '12||Malartic||1|
|Orlando Chiropractor and Affinity Health & Well... (Jan '12)||Feb '12||Washington Chiro||20|
|Judicial Watch Files Two Amicus Curiae Briefs W... (Feb '12)||Feb '12||Excellent||2|
|CFIA/Health Hazard Alert-Certain Dry Sausage So... (Feb '12)||Feb '12||Jim||1|
Find what you want!
Search Marketwire Forum Now
Copyright © 2017 Topix LLC